Loading company…
N.CER develops technology for early dementia detection based on brain blood flow changes.
N.CER develops early diagnosis and prevention services for dementia, measuring changes in brain blood flow during sensory stimulation. Founded in 2019, the company is based in Gwangju, South Korea, and received technology transfer from Gwangju Institute of Science and Technology. In 2020, it completed a prototype, received Ministry of Food and Drug Safety approval, and established a research institute. It plans to expand clinical sampling and improve its AI system.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in